Mortality News and Research

RSS

Researchers warn against relaxing Covid-19 restrictions prematurely

Relaxing Covid-19 restrictions could pave the way for new vaccine-resistant virus mutations – according to researchers at the University of East Anglia and the Earlham Institute.

27 Jul 2021

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Drinking up to 105 grams of alcohol per week - equivalent to 13 UK units of alcohol, less than six pints of medium-strength beer or just over a bottle of wine - may be associated with a decreased risk of heart attack, stroke, angina or death among those with cardiovascular disease (CVD).

27 Jul 2021

Measurement of death needs to be improved to save lives in future

In a world dealing with the worst public health crisis in a century, the current U.S. system for tracking deaths suffers from organizational, political and procedural flaws that actually put public health and safety at risk, and requires significant updates and reform to solve the problems laid bare by the COVID-19 pandemic.

27 Jul 2021

Global prevalence of dementia estimated to increase to more than 152 million by 2050

Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year 2050.

27 Jul 2021

Simple method to assess the risk of vascular inflammation for diabetes patients

A team of international scientists from Nanyang Technological University, Singapore (NTU Singapore), Tan Tock Seng Hospital (TTSH) in Singapore, and the Massachusetts Institute of Technology (MIT) has developed a simple method of extracting tiny biological particles from a person's blood and use them as biomarkers to assess the health of their blood vessels.

27 Jul 2021

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.

27 Jul 2021

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists from the UK have recently identified an antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine as a potential serum biomarker to diagnose active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server while awaiting peer review.

27 Jul 2021

Study may help refocus research efforts on adolescent and young adult cancer survivorship

Survival rates for adolescents and young adults diagnosed with cancer have varied considerably depending on cancer type.

26 Jul 2021

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.

25 Jul 2021

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

A recent study conducted as a part of the Real-Time Assessment of Community Transmission-2 (REACT-2) program has estimated the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies among adult populations in England.

25 Jul 2021

Researchers identify four themes as key contributors to diseases of despair in Pennsylvania

Financial instability, lack of infrastructure, a deteriorating sense of community and family fragmentation are key contributors to diseases of despair in Pennsylvania communities, according to Penn State College of Medicine and Highmark Health researchers.

23 Jul 2021

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers has received a $15 million award from the U.S. Centers for Disease Control and Prevention (CDC) to continue the current research for another year and expand to include children and focus on underserved populations.

23 Jul 2021

Global economic recovery at risk due to COVID-19 vaccine inequity

New Global Dashboard on COVID-19 Vaccine Equity finds low-income countries would add $38 billion to their GDP forecast for 2021 if they had the same vaccination rate as high-income countries. Global economic recovery at risk if vaccines are not equitably manufactured, scaled up and distributed.

23 Jul 2021

Higher net worth at midlife associated with longevity in US adults

One of the keys to a long life may lie in your net worth. In the first wealth and longevity study to incorporate siblings and twin pair data, researchers from Northwestern University analyzed the midlife net worth of adults (mean age 46.7 years) and their mortality rates 24 years later.

23 Jul 2021

New machine learning-based model predicts mortality risk of intensive care unit patients

A research team led by Dr Rosario Delgado from the UAB Department of Mathematics, in collaboration with the Hospital de Mataró, developed a new machine learning-based model that predicts the risk of mortality of intensive care unit patients according to their characteristics.

23 Jul 2021

Pre-transplant cardio-cerebrovascular diseases impact hematopoietic cell transplant outcomes

Hematopoietic cell transplantation (HCT) is a recognized treatment option for certain blood and bone marrow cancers as well as some autoimmune and hereditary disorders.

23 Jul 2021

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

A new study estimates vaccine effectiveness against COVID-19 mortality in England using the RDD approach.

22 Jul 2021

Can platelet size predict severity and mortality in COVID-19?

The ongoing COVID-19 pandemic has baffled researchers with its propensity to cause symptoms of largely unpredictable severity in the affected individuals. An exciting new study reports on the potential predictive value of platelet size in this situation. COVID-19 patients with severe disease often develop clots in vital organs, which leads to further complications. It is known that platelet size is a good indicator of activation.

22 Jul 2021

Study: Omega-3 levels in blood erythrocytes are good mortality risk predictors

Levels of omega-3 fatty acids in the blood are as good a predictor of mortality from any cause as smoking, according to a study involving the Hospital del Mar Medical Research Institute (IMIM), in collaboration with The Fatty Acid Research Institute in the United States and several universities in the United States and Canada.

22 Jul 2021

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published.

22 Jul 2021

Mortality News and Research

Researchers warn against relaxing Covid-19 restrictions prematurely

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Measurement of death needs to be improved to save lives in future

Global prevalence of dementia estimated to increase to more than 152 million by 2050

Simple method to assess the risk of vascular inflammation for diabetes patients

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Study may help refocus research efforts on adolescent and young adult cancer survivorship

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

Researchers identify four themes as key contributors to diseases of despair in Pennsylvania

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

Global economic recovery at risk due to COVID-19 vaccine inequity

Higher net worth at midlife associated with longevity in US adults

New machine learning-based model predicts mortality risk of intensive care unit patients

Pre-transplant cardio-cerebrovascular diseases impact hematopoietic cell transplant outcomes

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

Can platelet size predict severity and mortality in COVID-19?

Study: Omega-3 levels in blood erythrocytes are good mortality risk predictors

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News